-
Something wrong with this record ?
Cardiac remodeling and MMPs on the model of chronic daunorubicin-induced cardiomyopathy in rabbits
M. Adamcová, A. Potáčová, O. Popelová, M. Štěrba, Y. Mazurová, H. Aupperle, V. Geršl
Language English Country Czech Republic
NLK
Directory of Open Access Journals
from 1991
Free Medical Journals
from 1998
ProQuest Central
from 2005-01-01
Medline Complete (EBSCOhost)
from 2006-01-01
Nursing & Allied Health Database (ProQuest)
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 1998
- MeSH
- Chronic Disease MeSH
- Daunorubicin toxicity MeSH
- Fibrosis MeSH
- Financing, Organized MeSH
- Hydroxyproline metabolism MeSH
- Cardiomyopathies chemically induced metabolism prevention & control MeSH
- Cardiovascular Agents pharmacology MeSH
- Collagen metabolism MeSH
- Rabbits MeSH
- Drug Interactions MeSH
- Matrix Metalloproteinase 2 metabolism MeSH
- Matrix Metalloproteinase 9 metabolism MeSH
- Disease Models, Animal MeSH
- Myocardium enzymology pathology MeSH
- Antibiotics, Antineoplastic toxicity MeSH
- Razoxane pharmacology MeSH
- Ventricular Remodeling physiology MeSH
- Animals MeSH
- Check Tag
- Rabbits MeSH
- Male MeSH
- Animals MeSH
The matrix metalloproteinases (MMPs) play a key role during cardiac remodeling. The aim of the study was to investigate the changes in collagenous proteins and MMPs in the model of non-ischemic, anthracycline-induced chronic cardiomyopathy in rabbits using both biochemical and histological approaches. The study was carried out in three groups of Chinchilla male rabbits: 1) daunorubicin (3 mg/kg, once weekly for 10 weeks), 2) control (saline in the same schedule), 3) daunorubicin with the cardioprotectant dexrazoxane (60 mg/kg, before each daunorubicin). Morphological changes in the myocardium of daunorubicin-treated animals were characterized by focal myocardial interstitial fibrosis of different intensity. The subsequent proliferation of the fibrotic tissue was marked by an increased content of both collagen types I and III, which resulted in their typical coexpression in the majority of bundles of fibers forming either smaller or larger scars. Biochemical analysis showed a significantly increased concentration of hydroxyproline, mainly in the pepsin-insoluble fraction of collagenous proteins, in the daunorubicin-treated group (1.42±0.12 mg/g) as compared with the control (1.03±0.04 mg/g) and dexrazoxane (1.07±0.07 mg/g) groups. Dexrazoxane co-administration remarkably reduced the cardiotoxic effects of daunorubicin to the extent comparable with the controls in all evaluated parameters. Using zymography, it was possible to detect only a gelatinolytic band corresponding to MMP-2 (MMP-9 activity was not detectable). However, no significant changes in MMP-2 activity were determined between individual groups. Immunohistochemical analysis revealed increased MMP-2 expression in both cardiomyocytes and fibroblasts. Thus, this study has revealed specific alterations in the collagen network in chronic anthracycline cardiotoxicity in relationship to the expression and activity of major MMPs.
References provided by Crossref.org
Lit.: 16
- 000
- 00000naa 2200000 a 4500
- 001
- bmc11004227
- 003
- CZ-PrNML
- 005
- 20111210202606.0
- 008
- 110307s2010 xr e eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.931797 $2 doi
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Adamcová, Michaela, $d 1964- $7 xx0064762
- 245 10
- $a Cardiac remodeling and MMPs on the model of chronic daunorubicin-induced cardiomyopathy in rabbits / $c M. Adamcová, A. Potáčová, O. Popelová, M. Štěrba, Y. Mazurová, H. Aupperle, V. Geršl
- 314 __
- $a Department of Physiology, Charles University in Prague, Faculty of Medicine, Hradec Králové
- 504 __
- $a Lit.: 16
- 520 9_
- $a The matrix metalloproteinases (MMPs) play a key role during cardiac remodeling. The aim of the study was to investigate the changes in collagenous proteins and MMPs in the model of non-ischemic, anthracycline-induced chronic cardiomyopathy in rabbits using both biochemical and histological approaches. The study was carried out in three groups of Chinchilla male rabbits: 1) daunorubicin (3 mg/kg, once weekly for 10 weeks), 2) control (saline in the same schedule), 3) daunorubicin with the cardioprotectant dexrazoxane (60 mg/kg, before each daunorubicin). Morphological changes in the myocardium of daunorubicin-treated animals were characterized by focal myocardial interstitial fibrosis of different intensity. The subsequent proliferation of the fibrotic tissue was marked by an increased content of both collagen types I and III, which resulted in their typical coexpression in the majority of bundles of fibers forming either smaller or larger scars. Biochemical analysis showed a significantly increased concentration of hydroxyproline, mainly in the pepsin-insoluble fraction of collagenous proteins, in the daunorubicin-treated group (1.42±0.12 mg/g) as compared with the control (1.03±0.04 mg/g) and dexrazoxane (1.07±0.07 mg/g) groups. Dexrazoxane co-administration remarkably reduced the cardiotoxic effects of daunorubicin to the extent comparable with the controls in all evaluated parameters. Using zymography, it was possible to detect only a gelatinolytic band corresponding to MMP-2 (MMP-9 activity was not detectable). However, no significant changes in MMP-2 activity were determined between individual groups. Immunohistochemical analysis revealed increased MMP-2 expression in both cardiomyocytes and fibroblasts. Thus, this study has revealed specific alterations in the collagen network in chronic anthracycline cardiotoxicity in relationship to the expression and activity of major MMPs.
- 650 _2
- $a financování organizované $7 D005381
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a protinádorová antibiotika $x toxicita $7 D000903
- 650 _2
- $a kardiomyopatie $x chemicky indukované $x metabolismus $x prevence a kontrola $7 D009202
- 650 _2
- $a kardiovaskulární látky $x farmakologie $7 D002317
- 650 _2
- $a chronická nemoc $7 D002908
- 650 _2
- $a kolagen $x metabolismus $7 D003094
- 650 _2
- $a daunomycin $x toxicita $7 D003630
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a lékové interakce $7 D004347
- 650 _2
- $a fibróza $7 D005355
- 650 _2
- $a hydroxyprolin $x metabolismus $7 D006909
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a matrixová metaloproteinasa 2 $x metabolismus $7 D020778
- 650 _2
- $a matrixová metaloproteinasa 9 $x metabolismus $7 D020780
- 650 _2
- $a myokard $x enzymologie $x patologie $7 D009206
- 650 _2
- $a králíci $7 D011817
- 650 _2
- $a razoxan $x farmakologie $7 D011929
- 650 _2
- $a remodelace komor $x fyziologie $7 D020257
- 700 1_
- $a Potáčová, Anna. $7 xx0193799
- 700 1_
- $a Popelová, Olga. $7 _BN001885
- 700 1_
- $a Štěrba, Martin, $d 1979- $7 xx0076492
- 700 1_
- $a Mazurová, Yvona, $d 1951- $7 xx0054511
- 700 1_
- $a Aupperle, H. $7 gn_A_00010138
- 700 1_
- $a Geršl, Vladimír, $d 1946-2015 $7 nlk19990073168
- 773 0_
- $w MED00003824 $t Physiological research $g Roč. 59, č. 5 (2010), s. 831-836 $x 0862-8408
- 856 41
- $u http://www.biomed.cas.cz/physiolres/pdf/59/59_831.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 1
- 990 __
- $a 20110303103805 $b ABA008
- 991 __
- $a 20110429125057 $b ABA008
- 999 __
- $a ok $b bmc $g 831575 $s 696259
- BAS __
- $a 3
- BMC __
- $a 2010 $b 59 $c 5 $m Physiological research $x MED00003824 $d 831-836
- LZP __
- $a 2011-14/ipme